International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2026   Volume 16   Issue 1

Generative AI Meets Natural Product Chemistry: A Critical Review of Molecular Design, Synthetic Feasibility, Bioactivity Prediction, and Safety Validation
Download PDF


, , ,
  1. Department of Artificial Intelligence for Medicinal Mushroom and Fungal Metabolites, Faculty of Pharmacy, University of Bologna, Bologna, Italy.
  2. Department of Machine Learning for Drug Synergy and Toxicity, Faculty of Pharmacy, University of Turin, Turin, Italy.
  3. Department of Phytochemical Informatics, Faculty of Pharmacy, Sapienza University of Rome, Rome, Italy.
Citation
Vancouver
Ferraro L, Ricci M, Moretti G, Greco P. Generative AI Meets Natural Product Chemistry: A Critical Review of Molecular Design, Synthetic Feasibility, Bioactivity Prediction, and Safety Validation. Int J Pharm Phytopharmacol Res. 2026;16(1):60-70. https://doi.org/10.51847/qSMlQOLj14
APA
Ferraro, L., Ricci, M., Moretti, G., & Greco, P. (2026). Generative AI Meets Natural Product Chemistry: A Critical Review of Molecular Design, Synthetic Feasibility, Bioactivity Prediction, and Safety Validation. International Journal of Pharmaceutical And Phytopharmacological Research, 16(1), 60-70. https://doi.org/10.51847/qSMlQOLj14
Download citation:   EndNote   RIS
Article Link:
Downloads: 33
Views: 113
Abstract

Generative AI is increasingly used to support molecular design, chemical space exploration, and compound prioritisation, creating new opportunities for natural product chemistry while also raising important questions about chemical realism and validation. This critical review evaluates how generative models may contribute to natural product-inspired scaffold generation, analogue design, molecular novelty, diversity, bioactivity prediction, synthetic feasibility assessment, ADMET screening, toxicity prediction, and safety validation. The review takes a cautious interpretive approach, treating generated structures as design hypotheses rather than validated chemical, biological, or translational entities. Particular attention is given to the structural complexity of natural products, including stereochemistry, biosynthetic diversity, functional-group density, and the difficulty of distinguishing natural product likeness from biological relevance. The synthesis argues that generative AI can expand ideation, prioritise candidate chemical regions, and integrate multi-objective design constraints, but its outputs remain vulnerable to invalid structures, unrealistic stereochemistry, synthetic accessibility overestimation, false-positive bioactivity prediction, target-context mismatch, ADMET uncertainty, toxicity underprediction, benchmark bias, data leakage, and weak uncertainty reporting. The main conclusion is that generative AI has genuine value for natural product-inspired molecular exploration only when coupled to chemically informed constraints, retrosynthetic review, experimentally grounded bioactivity testing, safety assessment, uncertainty calibration, and transparent reporting. Future research should prioritise domain-specific datasets, stereochemistry-aware generation, synthesis-linked evaluation, biologically meaningful objectives, and validation pipelines that preserve the expertise of natural product chemists.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 4
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.